Literature DB >> 8257679

NMR solution structure and flexibility of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa.

C McInnes1, F D Sönnichsen, C M Kay, R S Hodges, B D Sykes.   

Abstract

A synthetic peptide antigen corresponding to the C-terminus of Pseudomonas aeruginosa K strain pilin has been studied by one and two-dimensional NMR techniques. This peptide exists in two isomeric forms which arise as a result of the I138-P139 amide bond. An ensemble of solution conformations for the trans form of this 17-residue disulfide-bridged peptide (PAK 128-144) has been generated using a simulated annealing procedure in conjunction with distance and torsion angle restraints derived from NMR data. One major class of backbone conformations has been identified for this potential synthetic vaccine and indicates the presence of two beta-turns in the region 134-142. The region that has been established as the epitope for the monoclonal antibody PK99H is consistent with the region of the major conformers that exhibit the most definition in the ensemble (134-140) and also includes a type I beta-turn from residues 134 to 137. The generated structures are also consistent with observed NOEs characteristic of beta-turns and amide proton temperature coefficient data, which indicate the presence of two turns between residues 134 and 142. The presence of secondary structure within the epitope substantiates the theory that immunogenic regions of proteins are those which contain surface-exposed structural elements such as beta-turns. Further implications of the structure on antigenicity and cross-reactivity are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257679     DOI: 10.1021/bi00212a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  The central variable V2 region of the CS31A major subunit is involved in the receptor-binding domain.

Authors:  P Di Martino; J P Girardeau; M Der Vartanian; B Joly; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

2.  Folded conformations of antigenic peptides from riboflavin carrier protein in aqueous hexafluoroacetone.

Authors:  S Bhattacharjya; S K Awasthi; P R Adiga; P Balaram
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

3.  Synthetic peptide vaccine development: designing dual epitopes into a single pilin peptide immunogen generates antibody cross-reactivity between two strains of Pseudomonas aeruginosa.

Authors:  Clifton Hackbarth; Robert S Hodges
Journal:  Chem Biol Drug Des       Date:  2010-08-30       Impact factor: 2.817

4.  Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa.

Authors:  Daniel J Kao; Robert S Hodges
Journal:  Chem Biol Drug Des       Date:  2009-07       Impact factor: 2.817

5.  Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice.

Authors:  M A Farinha; B D Conway; L M Glasier; N W Ellert; R T Irvin; R Sherburne; W Paranchych
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa.

Authors:  Daniel J Kao; Mair E A Churchill; Randall T Irvin; Robert S Hodges
Journal:  J Mol Biol       Date:  2007-09-19       Impact factor: 5.469

7.  Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.

Authors:  R Hertle; R Mrsny; D J Fitzgerald
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.